Lymphocyte isolation (T cells, B cells, NK cells)
Lymphocyte isolation
(T cells, B cells, NK cells)
Improve consistency, efficiency, and quality with freshly collected immune cells
![PBMC-Lymph-flowchart PBMC-Lymph-flowchart](https://stage.sanguinebio.com/wp-content/uploads/2022/08/PBMC-Lymph-flowchart.png)
One partner for sample collection and cell isolation
Whole blood collection takes place in the comfort of the donor's home. T cells, B cells, and/or NK cells are isolated within 24 hours of venipuncture collection, cryopreserved, and stored in liquid nitrogen.
![Quality Quality](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Quality.png)
![Quality Quality](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Quality.png)
![Quality Quality](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Quality.png)
QUALITY
Typical viability and purity ≥95% (disease-dependent)
![Method Method](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Method.png)
![Method Method](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Method.png)
![Method Method](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Method.png)
METHOD
Negative or positive selection
![Final Product Final Product](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Final-Product.png)
![Final Product Final Product](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Final-Product.png)
![Final Product Final Product](https://stage.sanguinebio.com/wp-content/uploads/2022/08/Final-Product.png)
FINAL PRODUCT
Aliquots of 5-10 million cells
Maximize results with flexible study size, design, and scope:
- Procure PBMCs or plasma/serum concurrently with T cells
- Specify inclusion/exclusion criteria (e.g., CLIA confirmed hepatitis B/C, HIV negative)
- NGS Human Leukocyte Antigen (HLA) typing available
- Multiple time points or event-based collection with recallable donor community (95% study retention)
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.
Publications using Sanguine PBMCs:
Cell
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
>
PLoS Pathogens
ZBTB2 represses HIV-1 transcription and is
regulated by HIV-1 Vpr
and cellular DNA damage responses
>
Hear from our Community:
Learn More about Donor-Centric Collection - experiment
To provide you with an accurate quote,
please complete the short form.
Alternatively, to speak with someone
directly, please contact:
Phone: 818-462-8290
Email: